Morphine for the Treatment of Pain in Patients With Breast Cancer
Completed
Roswell Park Cancer Institute
1992-05-01
RATIONALE: Morphine helps to relieve the pain associated with cancer surgery. Giving morphine
in different ways may offer more pain relief.
PURPOSE: This randomized clinical trial is studying how well morphine injected directly into
the underarm area works compared with morphine injected into the back of the shoulder in
treating pain in patients who have breast cancer and who are undergoing axillary lymph node
dissection.
Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
Completed
Cephalon
Phase 3
2005-01-01
The purpose of this study is to evaluate the safety and tolerability of OraVescent fentanyl
when used long-term to relieve breakthrough pain in opioid tolerant cancer patients.
OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients
Completed
Cephalon
Phase 3
2004-04-01
The purpose of this study is to evaluate the long-term safety and efficacy of OraVescent
fentanyl to treat breakthrough pain episodes in cancer patients who are already opioid
tolerant.
The purpose of this study is to see whether injection of hydromorphone through a subcutaneous
injection device is more effective in treating breakthrough cancer pain than oral morphine.
A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Elective Colonoscopy
Completed
Bio Analytical Research Corporation
Phase 2
2003-01-01
This study was designed to assess the safety and efficacy of AQUAVAN® Injection in providing
adequate sedation in patients undergoing colonoscopy. Prior to the procedure, patients
received fentanyl citrate for pain management followed five minutes later by AQUAVAN®
Injection for sedation. Throughout the procedure, study personnel assessed the patient's
vital signs and depth of sedation. After the procedure, the patient, physician, and an
evaluator were asked to complete satisfaction surveys.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
